OpenAlex
PricingAboutJobs
Log inGet started
Work

FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor–Positive, HER2-Negative Metastatic Breast Cancer

HTML

Year: 2015
Type: article
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-15-1185
Authors: Julia A. Beaver, Laleh Amiri-Kordestani, Rosane Charlab, Wei Chen, Todd Palmby, Amy Tilley, Jeanne Fourie Zirkelbach, Jingyu Yu, Qi Liu, Liang Zhao, Joyce Crich, Xiao Hong Chen, Minerva Hughes, Erik Bloomquist, Shenghui Tang, Rajeshwari Sridhara, Paul G. Kluetz, Geoffrey Kim, Amna Ibrahim, Richard Pazdur, Patricia Cortazar
Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research
Language: English

Topic: Advanced Breast Cancer Therapies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: palbociclib, estrogen receptor-positive breast cancer, HER2-negative breast cancer, metastatic breast cancer, postmenopausal women, letrozole, endocrine therapy, accelerated FDA approval, progression-free survival, neutropenia, drug approval
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2137620209
FWCI: 14.7
Cites: 9
Cited by: 401
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms